Home > Insider Trading > Filing (0000912282-24-000249)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1509261	Rezolute Inc.	RZLT	Pharmaceutical Preparations (2834)	273440894

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1768406	Young-Jin Kim	C/O Rezolute, Inc. 275 Shoreline Drive, Suite 500 Redwood City CA 94065		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2022-07-22	78,947	$3.80	78,947	No	4	P	Direct
Common Shares	Acquisiton	2024-03-07	36,503	$1.91	115,450	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Shares	5,942,617	Indirect	Held by Handok, Inc.

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.8969 to $1.9533, inclusive. The reporting person undertakes to provide to Rezolute, Inc., any security holder of Rezolute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The reporting person disclaims beneficial ownership of the securities held by Handok, Inc., except to the extent of his pecuniary interest therein, if any.